GeoVax Labs, Inc.
GOVX
NASDAQ·Healthcare·Biotechnology·Mkt cap $2.1M
$0.29
▲ +2.22%
P/E
—
Mkt Cap
$2.1M
52-Wk Range
$0.28–$15.75
52-Week Range
$0.28 - $15.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 97.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary MVA virus-like particle vaccine platform with broad applicability
- Strategic partnerships with NIH, CDC, and U.S. Department of Defense
- Diversified pipeline reducing development risk across multiple therapeutic areas
- Established relationships with leading research institutions and universities
Bear Case
1 risk
- Very high volatility (beta 3.7). Expect 3x market swings. Position size accordingly.
Growth
Stable outlook
Advancement of vaccine candidates through clinical development stages
Value
Valuation data unavailable
Momentum
Falling
-75.8% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying GOVX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
JUL 27, 2026
Reported EPS of -$0.97 vs -$2.16 consensus (+55.1% surprise).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+55.1%
Revenue trend · last 8Q
—
—
—
+183%
-100%
-100%
-100%
-100%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.8M
$864.4K
$1.6M
$852.3K
$0
$0
$0
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
1 analyst · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: D. Boral Capital · Apr 16, 2026
vs Industry
How GOVX stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related